Shares Outstanding Adjustment Factor

The following section summarizes insights on 's Shares Outstanding Adjustment Factor:

• AstraZeneca's latest twelve months revenue is 43.19 billion
• AstraZeneca's revenue for fiscal years ending December 2020 to 2024 averaged 32.589 billion.
• AstraZeneca's operated at median revenue of 35.936 billion from fiscal years ending December 2020 to 2024.
• Looking back at the last 5 years, AstraZeneca's revenue peaked in December 2024 at 43.19 billion.
• AstraZeneca's revenue hit its 5-year low in December 2020 of 19.464 billion.
• AstraZeneca's revenue decreased in 2023 (35.936 billion, -2.1%) and increased in 2020 (19.464 billion, +5.7%), 2021 (27.669 billion, +42.2%), 2022 (36.688 billion, +32.6%), and 2024 (43.19 billion, +20.2%).